Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07743086 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing

StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
The goal of this clinical trial is to: * In Phase 1 (observational) to develop an algorithm for treatment of Duffy-null positive patients for chemotherapy dosing * In Phase 2 (interventional), use the algorithm created in phase 1 to adjust chemotherapy dosing for Duffy-null patients
Trial Details
NCT Number NCT07743086
Lead Sponsor Barbara Ann Karmanos Cancer Institute
Conditions
(from sponsor)		 Solid Tumor Cancer
Enrollment 886 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov